@article{JTD16080,
author = {Renfang Wang and Tanlun Yu},
title = {Prof. Yi Hu: a doctor of acute insight and action},
journal = {Journal of Thoracic Disease},
volume = {9},
number = {Suppl 11},
year = {2017},
keywords = {},
abstract = {Several months ago, Prof. Yi Hu and his team were working on a clinical research project, which aimed at finding the best strategy to postpone lung cancer’s resistance towards targeted therapy. A new medicine that could reverse drug resistance came out while they were still on the early phase of the research project. Prof. Hu said: “There is no need to design the rest of the trial tests, because we have a more targeted agent. We don’t need to combine chemotherapy against our targets anymore!”},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/16080}
}